Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
45.00
+2.09 (4.87%)
At close: Jun 17, 2026, 4:00 PM EDT
45.48
+0.48 (1.07%)
After-hours: Jun 17, 2026, 7:51 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.2 billion as of June 17, 2026. Its market cap has increased by 153.02% in one year.
Market Cap
3.20B
Enterprise Value
1.75B
1-Year Change
153.02%
Ranking
Category
Stock Price
$45.00
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.20B, an increase of 482.77%. That is a compound annual growth rate of 68.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 3.20B | -33.49% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.44B |
| Telix Pharmaceuticals | 3.31B |
| Relay Therapeutics | 3.26B |
| Arcutis Biotherapeutics | 3.20B |
| Beam Therapeutics | 3.10B |
| Dyne Therapeutics | 3.10B |
| Arcus Biosciences | 3.04B |
| Alumis | 2.93B |